GeneDx Holdings
67 hedge funds and large institutions have $403M invested in GeneDx Holdings in 2021 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 34 closing their positions.
593% more call options, than puts
Call options by funds: $13.7M | Put options by funds: $1.98M
105% more capital invested
Capital invested by funds: $197M → $403M (+$206M)
62% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 34
46% more funds holding
Funds holding: 46 → 67 (+21)
0.64% more ownership
Funds ownership: 1.26% → 1.9% (+0.64%)
78% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 9
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$66.7M |
| 2 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$53.3M |
| 3 |
Alkeon Capital Management
New York
|
+$36.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$32.1M |
| 5 |
SHCM
Sachem Head Capital Management
New York
|
+$23.6M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$27.3M |
| 2 |
LA
Linden Advisors
New York
|
-$23.2M |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$13.8M |
| 4 |
Blackstone Inc
New York
|
-$13.5M |
| 5 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$12.9M |
WGS Hedge Fund Activity: Q1 2021 in Review
67 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q1 2021, worth a combined $403M — up 105% from $197M a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new WGS positions and 34 closed out — a net gain of 21 holders — while 2 added to existing stakes and 9 trimmed.
The largest buyer was ARK Investment Management, opening a new position worth an estimated $66.7M. The largest seller was Millennium Management, cutting an estimated $27.3M.
- 67 institutional investors held GeneDx Holdings (WGS) as of Q1 2021, up from 46 in Q4 2020.
- Funds reported $403M of GeneDx Holdings stock for Q1 2021, up 105% quarter-over-quarter.
- 55 funds opened new GeneDx Holdings positions in Q1 2021 and 34 closed out, a net change of +21 holders.
- The largest GeneDx Holdings buyer in Q1 2021 was ARK Investment Management, an estimated $66.7M added.
- The largest GeneDx Holdings seller in Q1 2021 was Millennium Management, an estimated $27.3M sold.
Based on aggregated 13F filings for Q1 2021.